Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Breast Neoplasms 285Lymphoma 201Lymphoma, Large B-Cell, Diffuse 167Sarcoma 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Hodgkin Disease 85Lymphoma, Non-Hodgkin 78Burkitt Lymphoma 67Lymphoma, Follicular 61Leukemia 58Ovarian Neoplasms 50Neoplasms 50Triple Negative Breast Neoplasms 49Lymphoma, Mantle-Cell 48Multiple Myeloma 47Neuroblastoma 44Carcinoma, Hepatocellular 44Neoplasm Metastasis 41Lymphoma, B-Cell 33Lymphoma, Large-Cell, Anaplastic 31Lymphoma, T-Cell, Peripheral 27Recurrence 26Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Osteosarcoma 25Liposarcoma 25Leiomyosarcoma 25Urinary Bladder Neoplasms 23Lymphoma, Large-Cell, Immunoblastic 23Liver Neoplasms 22Endometrial Neoplasms 21

Interventions

Docetaxel 8Filgrastim 5Cisplatin 5Radiotherapy 4Etoposide 3Erlotinib Hydrochloride 3Cetuximab 3Capecitabine 3Bevacizumab 3sargramostim 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1pentetreotide 1oncogene protein E7, Human papillomavirus type 16 1olaparib 1oblimersen 1lutetium Lu 177 dotatate 1etoposide phosphate 1entinostat 1enasidenib 1cevimeline 1apatinib 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Esthesioneuroblastoma, Olfactory × Doxorubicin × Clear all
NCT00509665 2018-07-12

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Medical University of South Carolina

Phase 2 Completed
18 enrolled 9 charts
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡